Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Anti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study.
The high cost of spasticity in multiple sclerosis to individuals and society.
A modified superantigen rescues Ly6G(-)CD11b(+)blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE.
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Systematic Review: The effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis.
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
4-Аminopyridine sequesters intracellular Ca(2+) which triggers exocytosis in excitable and non-excitable cells.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
Quantifying progression of multiple sclerosis via classification of depth videos.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
[Affective and psychotic disorders in multiple sclerosis].
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Notch Signaling and T-Helper Cells in EAE/MS.
P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
The role of angiogenesis in the pathology of multiple sclerosis.

Pages